Riley Ennis - Co-Founder and COO @ Freenome - Crunchbase Person Profile

Start Free Trial

Overview

Number of Founded Organizations

CB Rank (Person)

Primary Job Title Co-Founder and COO
Primary Organization
Freenome

Location San Francisco, California, United States
Regions San Francisco Bay Area, West Coast, Western US
Gender Male

LinkedIn View on LinkedIn
X (Twitter) View on X

Riley is a Thiel Fellow who created a cancer vaccine with his previous company Immudicon as Co-Founder & Chair. Co-Founder, COO at Freenome.

Jobs

Number of Current Jobs

has

current jobs including

Co-Founder

at

,

Co-Founder and COO

at

, and

Thiel Fellow

at

The Thiel Foundation

.

Oncolinx Co-FounderOct 2014
Freenome Co-Founder and COOJan 2014
The Thiel Foundation Thiel FellowDec 2013
Immudicon Co-Founder, ChairJan 2013

Related Hubs

Hub Name	CB Rank (Hub)
Health Diagnostics Companies With Less Than $1B in Revenue (Top 10K)	8,398
Fidelity Portfolio Companies	23,884
Acquired San Francisco Bay Area Companies (Top 10K)	2,010
Personal Health Companies that Exited	18,991
EcoR1 Capital Portfolio Companies	55,958
Western US Acquired Companies With Fewer Than 1000 Employees (Top 10K)	1,406
Biotechnology Acquired Companies With More Than $50M in Revenue	22,342
California Acquired Companies With More Than $50M in Revenue	21,100
Personal Health Companies With More Than 10 Employees (Top 10K)	10,769
ArrowMark Partners Portfolio Companies	87,461

Education

studied at

Dartmouth College

,

Yale School of Management

, and

The Johns Hopkins University

.

Dartmouth College B.AMolecular Biology20112016
Yale School of Management MBA20132013
The Johns Hopkins University Master's in Biotechnology20142017

Events

Number of Events

has participated in

events. They most recently attended, or will attend,

Internapalooza 2018

on

Aug 2, 2018

.

Internapalooza 2018 Speaker San Francisco, California, United States, North AmericaAug 2, 2018
Collision 2017 Speaker New Orleans, Louisiana, United States, North AmericaMay 2, 2017

Recent News and Activity

Number of News Articles

News•

Mar 22, 2018

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated